ImageneBio Inc. Live Stock Price Today, Share Analysis and Chart

Name: ImageneBio Inc.: Is Infosys Ltd. worth buying?
Item: ImageneBio Inc.
Rating: 1.13250
Author: Trendlyne DVM scores

about

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product ca...

15.20 -1.17 (-7.15%)

34.71% Fall from 52W High

25,455

XNAS Volume

XNAS 29 Jul, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for ImageneBio Inc. is on 08 Aug 2025 for the purpose of Ikena Oncology Inc Second Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

4.0 / 100

Technically Neutral

41.3 / 100

1Yr Price target downside is -80%

2 analysts

ImageneBio Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

ImageneBio Inc. Live Stock Price Today, Share Analysis and Chart

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product ca...

34.71% Fall from 52W High

SWOT Analysis

ImageneBio Inc. Live Price Chart